Lindbrook Capital, LLC Nektar Therapeutics Transaction History

Lindbrook Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$3.04 - $5.14 $1,854 - $3,135	-610 Reduced 87.64%	86 $0
Q2 2022 Aug 01, 2022	SELL	$3.17 - $6.17 $2,209 - $4,300	-697 Reduced 50.04%	696 $3,000
Q1 2022 Apr 21, 2022	BUY	$4.16 - $13.72 $5,695 - $18,782	1,369 Added 5704.17%	1,393 $8,000
Q4 2021 Jan 18, 2022	BUY	$10.83 - $18.41 $259 - $441	24 New	24 $0

128

111M

150K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $219M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Lindbrook Capital, LLC with notifications on news.